Hyperglycemia in sepsis is a risk factor for development of type II diabetes

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 263-269

  Gornik, Ivan ^a   Vujaklija, Ana ^a   Lukić, Edita ^b   Madžarac, Goran ^b   GašparoviÍ, Vladimir ^a  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Hyperglycemia; Risk factor; Sepsis; Severity of sepsis; Type 2 diabetes mellitus

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; APACHE; ARTICLE; BODY MASS; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK FACTOR; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77953292248     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.10.002     Document Type: Article

References (44)

1. Van Cromphaut S.J., Vanhorebeek I., Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des 2008, 14:1887-1899.
2. Van den Berghe G. Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 2002, 18:509-528.
3. Langouche L., Van den Berghe G. The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 2006, 35. 777-91, ix.
4. McCowen K.C., Malhotra A., Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 2001, 17:107-124.
5. Grimble R.F. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002, 5:551-559.
6. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 2002, 5:377-383.
7. Marik P.E., Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004, 30:748-756.
8. Aljada A., Ghanim H., Assian E., et al. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 2002, 51:487-491.
9. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res 2001, 15:533-551.
10. Mehta V.K., Hao W., Brooks-Worrell B.M., et al. Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 1994, 130:208-214.
11. Benfield T., Jensen J.S., Nordestgaard B.G. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007, 50:549-554.
12. Christiansen C., Toft P., Jorgensen H.S., et al. Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 2004, 30:1685-1688.
13. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Eng J Med 2001, 1359-1367.
14. Malmberg K., Norhammar A., Wedel H., et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999, 99:2626-2632.
15. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
16. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829..
17. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
19. Krishnan J.A., Parce P.B., Martinez A., et al. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 2003, 124:297-305.
20. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31(Suppl 1):S55-S60.
21. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
22. Krinsley J.S. The severity of sepsis: yet another factor influencing glycemic control. Crit Care (London, England) 2008, 12:194.
23. Waeschle R.M., Moerer O., Hilgers R., et al. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care (London, England) 2008, 12:R129.
24. Ali N.A., O'Brien J.M., Dungan K., et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008, 36:2316-2321.
25. Dossett L.A., Cao H., Mowery N.T., et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008, 74:679-685. discussion 685.
26. Egi M., Bellomo R., Stachowski E., et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252.
27. Gornik I., Vujaklija A., Lukic E., et al. Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus. Acta diabetologica 2009, in press. 10.1007/s00592-009-0115-6.
28. Preissig C.M., Rigby M.R. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care (London, England) 2009, 13:R27.
29. Rattanataweeboon P., Vilaichone W., Vannasaeng S. Stress hyperglycemia in patients with sepsis. J Med Assoc Thai 2009, 92(Suppl 2):S88-S94.
30. Leonidou L., Michalaki M., Leonardou A., et al. Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival. Am J Med Sci 2008, 336:467-471.
31. Griesdale D.E., Tremblay M.H., McEwen J., et al. Glucose control and mortality in patients with severe traumatic brain injury. Neurocrit Care 2009.
32. Sen K., Mukherjee A.K., Dharchowdhury L., et al. A study to find out the proportion of prediabetes in patients with acute coronary syndrome in a medical college of Kolkata. J Indian Med Assoc 2008, 106:776-778.
33. Nakamura T., Ako J., Kadowaki T., et al. Impact of acute hyperglycemia during primary stent implantation in patients with ST-elevation myocardial infarction. J Cardiol 2009, 53:272-277.
34. Goran K.P. The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 2007, 28(2042):2042-2043. author reply.
35. Ishihara M., Inoue I., Kawagoe T., et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 2006, 27:2413-2419.
36. Timmer J.R., Ottervanger J.P., Bilo H.J., et al. Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM 2006, 99:237-243.
37. Schiele F., Descotes-Genon V., Seronde M.F., et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 2006, 23:1370-1376.
38. Deedwania P., Kosiborod M., Barrett E., et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008, 117:1610-1619.
39. Inzucchi S.E., Rosenstock J. Counterpoint: inpatient glucose management: a premature call to arms?. Diabetes Care 2005, 28:976-979.
40. Bryer-Ash M., Garber A.J. Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 2005, 28:973-975.
41. Garber A.J., Moghissi E.S., Bransome E.D., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004, 10(Suppl 2):4-9.
42. Thorell A., Nygren J., Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999, 2:69-78.
43. Clowes G.H., Martin H., Walji S., et al. Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 1978, 135:577-583.
44. Esteghamati A., Khalilzadeh O., Anvari M., et al. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 2008, 39:803-808.